Carl Zeiss Meditec AG

XETRA AFX.DE

Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities for the year ending September 30, 2024: USD 196.24 M

Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities is USD 196.24 M for the year ending September 30, 2024, a 237.38% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities for the year ending September 30, 2023 was USD -142.85 M, a -281.20% change year over year.
  • Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities for the year ending September 30, 2022 was USD -37.47 M, a 88.68% change year over year.
  • Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities for the year ending September 30, 2021 was USD -330.93 M, a -129.65% change year over year.
  • Carl Zeiss Meditec AG Net Cash Used Provided By Financing Activities for the year ending September 30, 2020 was USD -144.10 M, a -125.51% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
XETRA: AFX.DE

Carl Zeiss Meditec AG

CEO Dr. Markus Weber
IPO Date March 22, 2000
Location Germany
Headquarters Goschwitzer Strasse 51-52
Employees 4,823
Sector Health Care
Industries
Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Similar companies

NEM.DE

Nemetschek SE

USD 96.83

-0.09%

JEN.DE

Jenoptik AG

USD 21.85

0.23%

BC8.DE

Bechtle AG

USD 30.51

-2.87%

SHL.DE

Siemens Healthineers AG

USD 52.62

1.24%

StockViz Staff

January 15, 2025

Any question? Send us an email